Leibniz-Institute for Molecular Pharmacology (FMP)
The FMP conducts basic research in Molecular Pharmacology with the aim to identify novel bioactive molecules and to characterize their interactions with their biological targets in cells or organisms. These compounds are useful tools in basic biomedical research and may be further developed for the treatment, prevention, or diagnosis of disease.
To this aim FMP researchers study key biological processes and corresponding diseases, such as cancer, aging including osteoporosis, or neurodegeneration. They also develop and apply advanced technologies ranging from screening technologies over NMR based methods to proteomics and in vivo models.
To this aim FMP researchers study key biological processes and corresponding diseases, such as cancer, aging including osteoporosis, or neurodegeneration. They also develop and apply advanced technologies ranging from screening technologies over NMR based methods to proteomics and in vivo models.
A tour through the institute
Why not visit our laboratories? Our institute's videos take you on a virtual tour of the FMP. For a deeper look, please don't hesitate to contact our research groups directly.
Currently, 270 researchers and administration staff work at the institute. A directory is available under the Staff A-Z link.
A brief history
The FMP was founded in 1992 as a successor to the "Institut für Wirkstofforschung", an Institute of the Academy of Sciences of the GDR. It was renamed "Forschungsinstitut für Molekulare Pharmakologie" - hence, its acronym FMP. Then as now, the institute focused on proteins as basic structures of the lives of all cellular organisms.
From the beginning, the FMP has been a member of the Leibniz-Association and is now called Leibniz-Institut für Molekulare Pharmakologie. The FMP and seven other Berlin Leibniz-Institutes are legally represented by the Forschungsverbund Berlin e.V.